Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products. It also provides pet nutrition products for everyday nutritional needs; a range of therapeutic products to manage disease conditions; and various products with natural ingredients. The company's principal global and regional trademarks include Colgate, Palmolive, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom's of Maine, Sanex, Ajax, Axion, Fabuloso, Soupline, and Suavitel, as well as Hill's Science Diet, Hill's Prescription Diet, and Hill's Ideal Balance. It markets and sells its oral, personal and home care products to various retail and wholesale customers, and distributors; and pet nutrition products for dogs and cats through pet supply retailers and veterinarians. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Toilet preparations
Sub-IndustryHousehold Products
SectorConsumer Staples
SymbolNYSE:CL
CUSIP19416210
Phone212-310-2000
Debt
Debt-to-Equity Ratio-34.49
Current Ratio1.06
Quick Ratio0.74
Price-To-Earnings
Trailing P/E Ratio23.25
Forward P/E Ratio22.09
P/E Growth2.93
Sales & Book Value
Annual Sales$15.45 billion
Price / Sales3.75
Cash Flow$3.5079 per share
Price / Cash19.02
Book Value$0.28 per share
Price / Book238.29
Profitability
EPS (Most Recent Fiscal Year)$2.87
Net Income$2.02 billion
Net Margins13.97%
Return on Equity2,494.79%
Return on Assets20.54%
Miscellaneous
Employees35,900
Outstanding Shares867,740,000
Market Cap$56.78 billion
Colgate-Palmolive (NYSE:CL) Frequently Asked Questions
What is Colgate-Palmolive's stock symbol?
Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."
How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?
Colgate-Palmolive declared a quarterly dividend on Monday, June 18th. Investors of record on Wednesday, July 18th will be paid a dividend of $0.42 per share on Wednesday, August 15th. This represents a $1.68 dividend on an annualized basis and a yield of 2.52%. The ex-dividend date of this dividend is Tuesday, July 17th. View Colgate-Palmolive's Dividend History.
How will Colgate-Palmolive's stock buyback program work?
Colgate-Palmolive declared that its Board of Directors has initiated a share repurchase plan on Monday, June 18th 2018, which allows the company to buyback $5,000,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to purchase up to 9% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's board believes its stock is undervalued.
How were Colgate-Palmolive's earnings last quarter?
Colgate-Palmolive (NYSE:CL) issued its earnings results on Friday, July, 27th. The company reported $0.77 earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of $0.77. The company had revenue of $3.89 billion for the quarter, compared to analysts' expectations of $3.91 billion. Colgate-Palmolive had a net margin of 13.97% and a return on equity of 2,494.79%. Colgate-Palmolive's revenue was up 1.6% compared to the same quarter last year. During the same period last year, the firm posted $0.72 EPS. View Colgate-Palmolive's Earnings History.
When is Colgate-Palmolive's next earnings date?
What price target have analysts set for CL?
16 equities research analysts have issued twelve-month target prices for Colgate-Palmolive's shares. Their predictions range from $64.00 to $85.00. On average, they anticipate Colgate-Palmolive's share price to reach $71.3077 in the next twelve months. This suggests a possible upside of 6.9% from the stock's current price. View Analyst Price Targets for Colgate-Palmolive.
What is the consensus analysts' recommendation for Colgate-Palmolive?
16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 2 sell ratings, 11 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Colgate-Palmolive.
What are Wall Street analysts saying about Colgate-Palmolive stock?
Here are some recent quotes from research analysts about Colgate-Palmolive stock:
- 1. Wells Fargo & Co analysts commented, "We maintain our FY18/FY19 EPS estimates by $3.02/$3.27 and our $64 price target." (7/27/2018)
- 2. According to Zacks Investment Research, "Colgate lagged the industry in the past three months as its margins continue to be strained due to higher raw material and packaging costs. Notably, the company reported second straight quarter of negative gross margin and fourth consecutive quarter of operating margin decline in first-quarter 2018. Moreover, Colgate expects the backdrop to remain challenging in 2018 due to uncertain global markets and slowing category growth worldwide. However, the company has been popular with investors for its meet or beat earnings track record. Continuing with this trend, the company delivered an earnings beat in first-quarter 2018, after three consecutive quarters of in line earnings. Results continue to be driven by sales growth and significant market share gains. The company remains on track with the brand building and productivity maximization initiatives. It is also encouraged by the progress on Global Growth and Efficiency Program." (7/2/2018)
- 3. Jefferies Financial Group Inc analysts commented, "CL’s 4Q print was disappointing w/org sales of +2% (vs. +3.4% Street) and GM%/OI below expectations. 4Q EPS of $0.75 was in-line with revs/GM% miss partially offset by lower SG&A and $0.02 from taxes. FY18 guide implies tepid low-to-mid single digit % underlying EPS growth (ex-Tax Act/FX benefits), which should augment HPC group GM % worries w/higher commodity costs, constrained pricing, and need for higher investment. We expect CL’s shares to trade down." (1/26/2018)
Are investors shorting Colgate-Palmolive?
Colgate-Palmolive saw a decline in short interest during the month of July. As of July 13th, there was short interest totalling 12,306,432 shares, a decline of 23.9% from the June 29th total of 16,173,897 shares. Based on an average daily volume of 2,953,837 shares, the short-interest ratio is currently 4.2 days. Currently, 1.4% of the company's stock are short sold. View Colgate-Palmolive's Current Options Chain.
Who are some of Colgate-Palmolive's key competitors?
Some companies that are related to Colgate-Palmolive include Estee Lauder Companies (EL), Pola Orbis (PORBF), Coty (COTY), HYPERA S A/S (HYPMY), Edgewell Personal Care (EPC), Inter Parfums (IPAR), Mandom (MDOMF), Revlon (REV), Avon Products (AVP), e.l.f. Beauty (ELF), United-Guardian (UG), DS Healthcare Group (DSKX) and 2050 Motors (ETFM).
Who are Colgate-Palmolive's key executives?
Colgate-Palmolive's management team includes the folowing people:
- Mr. Ian M. Cook, Chairman, Pres & CEO (Age 65)
- Mr. Dennis J. Hickey, Vice Chairman (Age 70)
- Mr. Franck J. Moison, Vice Chairman (Age 64)
- Mr. Noel R. Wallace, Chief Operating Officer of Global Innovation & Growth and Hill's Pet Nutrition (Age 54)
- Mr. P. Justin Skala, Chief Operating Officer of North America, Europe, Africa/Eurasia and Global Sustainability (Age 58)
Has Colgate-Palmolive been receiving favorable news coverage?
News coverage about CL stock has trended somewhat positive on Friday, Accern reports. The research firm ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Colgate-Palmolive earned a news impact score of 0.07 on Accern's scale. They also assigned news coverage about the company an impact score of 44.81 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. View Recent Headlines for Colgate-Palmolive.
Who are Colgate-Palmolive's major shareholders?
Colgate-Palmolive's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.16%), Massachusetts Financial Services Co. MA (3.73%), Bank of New York Mellon Corp (2.32%), FMR LLC (0.91%), Renaissance Technologies LLC (0.83%) and OppenheimerFunds Inc. (0.78%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive.
Which institutional investors are selling Colgate-Palmolive stock?
CL stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Renaissance Technologies LLC, Morgan Stanley, Canada Pension Plan Investment Board, BlackRock Inc., Newport Trust Co, Russell Investments Group Ltd. and NN Investment Partners Holdings N.V.. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Stephen I Sadove and Victoria L Dolan. View Insider Buying and Selling for Colgate-Palmolive.
Which institutional investors are buying Colgate-Palmolive stock?
CL stock was purchased by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Charles Schwab Investment Advisory Inc., Bank of New York Mellon Corp, Flossbach Von Storch AG, Natixis, Intermede Investment Partners Ltd, Bessemer Group Inc. and Caisse DE Depot ET Placement DU Quebec. View Insider Buying and Selling for Colgate-Palmolive.
How do I buy shares of Colgate-Palmolive?
Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Colgate-Palmolive's stock price today?
One share of CL stock can currently be purchased for approximately $66.72.
How big of a company is Colgate-Palmolive?
Colgate-Palmolive has a market capitalization of $56.78 billion and generates $15.45 billion in revenue each year. The company earns $2.02 billion in net income (profit) each year or $2.87 on an earnings per share basis. Colgate-Palmolive employs 35,900 workers across the globe.
How can I contact Colgate-Palmolive?
Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]
MarketBeat Community Rating for Colgate-Palmolive (NYSE CL)
MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote "Outperform" if you believe CL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CL will underperform the S&P 500 over the long term. You may vote once every thirty days.
